To this end, we conducted a further human cohort study using normal liver tissues and HCC samples from recruited Asian patients, so as to verify our hypothesis of PRMT1 as the prognostic biomarker of HCC and clarify the underlying mechanisms between PRMT1 and HCC progression. Here, PRMT1 is linked to hepatocellular carcinoma.